Search results
Results From The WOW.Com Content Network
The concept of blocking PD-1 and PD-L1 for the treatment of cancer was first published in 2001. [6] Pharmaceutical companies began attempting to develop drugs to block these molecules, and the first clinical trial was launched in 2006, evaluating nivolumab.
Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. [5] [6] [10] Dostarlimab is a programmed death receptor-1 (PD-1)–blocking monoclonal antibody.
29126 60533 Ensembl ENSG00000120217 ENSMUSG00000016496 UniProt Q9NZQ7 Q9EP73 RefSeq (mRNA) NM_001314029 NM_001267706 NM_014143 NM_021893 RefSeq (protein) NP_001254635 NP_001300958 NP_054862 NP_068693 Location (UCSC) Chr 9: 5.45 – 5.47 Mb Chr 19: 29.34 – 29.37 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation ...
People have had severe infusion-related reactions to pembrolizumab. There have also been severe immune-related adverse effects including lung inflammation (including fatal cases) and inflammation of endocrine organs that caused inflammation of the pituitary gland, of the thyroid (causing both hypothyroidism and hyperthyroidism in different people), and pancreatitis that caused Type 1 diabetes ...
58205 Ensembl ENSG00000197646 ENSMUSG00000016498 UniProt Q9BQ51 Q9WUL5 RefSeq (mRNA) NM_025239 NM_021396 RefSeq (protein) NP_079515 NP_067371 Location (UCSC) Chr 9: 5.51 – 5.57 Mb Chr 19: 29.39 – 29.45 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Programmed cell death 1 ligand 2 (also known as PD-L2, B7-DC) is a protein that in humans is encoded by the PDCD1LG2 gene. PDCD1LG2 ...
PDL (i) Premier Development League, a former name of the U.S. minor soccer league now known as USL League Two; Pure Dumb Luck (Texan punk band) PDN – (i) Pull-Down Network; PDP (i) Programmable Data Processor; Performance Development Plan [1] PDQ (i) Pre-Defined Queries (Siebel packages) Pretty Damn Quick
FORWARD, The Foundation for Women's Health, Research and Development, accessed 11 September 2011. "Hospitals and Clinics in the UK offering Specialist FGM (Female Genital Mutilation) Services" Archived 28 March 2014 at the Wayback Machine, FORWARD, accessed 11 September 2011. "'Harmful' tradition continues in Britain", BBC News, 22 November 2000.
Cangrelor, sold under the brand name Kengreal among others, is a P2Y 12 inhibitor FDA approved as of June 2015 as an antiplatelet drug [5] for intravenous application. Some P2Y 12 inhibitors are used clinically as effective inhibitors of adenosine diphosphate-mediated platelet activation and aggregation. [5]